Related Experiment Video
Updated: Jun 1, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Modulation of DAPK1 expression by its alternative splice variant DAPK1-215 in cancer
QingShui Wang1, ShuYun Weng2, WenTing Zhong3
1Fujian-Macao Science and Technology Cooperation Base of Traditional Chinese Medicine-Oriented Chronic Disease Prevention and Treatment, Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350001, China. wangqingshui@fjnu.edu.cn.
Background:
Death-Associated Protein Kinase 1 (DAPK1) family members are calcium/calmodulin-regulated serine/threonine kinases implicated in cell death, normal development, and human diseases. However, the regulation of DAPK1 expression in cancer remains unclear.
Methods:
We examined the expression and functional impact of a DAPK1 splice variant, DAPK1-215, in multiple cancer cell lines. DAPK1 and DAPK1-215 expression levels were quantified by qRT-PCR and Western blotting. Cell migration, invasion, and proliferation assays were conducted in vitro, and a zebrafish model was employed to evaluate metastatic potential. RNA pull-down and CLIP-seq analyses were performed to identify potential RNA-binding proteins. Finally, clinical liver cancer specimens were analyzed to assess the prognostic relevance of DAPK1-215 and DAPK1 mRNA levels.
Results:
DAPK1-215 downregulated DAPK1 expression in liver, kidney, and gastric cancer cells by reducing DAPK1 mRNA stability. DAPK1-215 promoted migratory and invasive capabilities in liver and kidney cancer cells, but inhibited these processes in gastric cancer cells, without affecting cell proliferation. Mechanistically, DEAD-Box Helicase 3 X-Linked (DDX3X) stabilized both DAPK1-215 and DAPK1 mRNAs, suggesting that DAPK1-215 may act by competing for DDX3X binding to modulate DAPK1 mRNA stability. Importantly, high levels of DAPK1-215 correlated inversely with DAPK1 mRNA in liver cancer specimens and predicted poor prognosis, whereas high DAPK1 expression predicted improved patient outcomes.
Conclusions:
Our findings unveil DAPK1-215 as a molecular brake on DAPK1 expression, influencing cancer cell migration and invasion in a context-dependent manner. These results highlight the potential of DAPK1-215 as an important regulator of malignant progression and as a prognostic marker in liver cancer.
Insights
A novel splice variant, DAPK1-215, acts as a molecular brake on Death-Associated Protein Kinase 1 (DAPK1) expression, impacting cancer cell migration and invasion. DAPK1-215 serves as a prognostic marker for liver cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Death-Associated Protein Kinase 1 (DAPK1) is a serine/threonine kinase involved in cell death, development, and disease.
- The regulation of DAPK1 expression in cancer is not well understood.
Purpose of the Study:
- To investigate the expression and functional role of the DAPK1 splice variant, DAPK1-215, in various cancer types.
- To elucidate the mechanism by which DAPK1-215 affects DAPK1 expression and cancer cell behavior.
- To assess the prognostic significance of DAPK1-215 and DAPK1 in liver cancer.
Main Methods:
- Quantified DAPK1 and DAPK1-215 expression using qRT-PCR and Western blotting in cancer cell lines.
- Assessed cell migration, invasion, and proliferation in vitro and metastatic potential in a zebrafish model.
- Utilized RNA pull-down and CLIP-seq to identify RNA-binding proteins.
- Analyzed clinical liver cancer specimens for prognostic relevance.
Main Results:
- DAPK1-215 downregulated DAPK1 expression by reducing mRNA stability in liver, kidney, and gastric cancer cells.
- DAPK1-215 promoted migration and invasion in liver and kidney cancer but inhibited these in gastric cancer cells.
- DEAD-Box Helicase 3 X-Linked (DDX3X) stabilized both DAPK1 and DAPK1-215 mRNAs, suggesting competition for binding.
- High DAPK1-215 levels correlated with poor prognosis in liver cancer, while high DAPK1 predicted better outcomes.
Conclusions:
- DAPK1-215 functions as a molecular brake on DAPK1 expression, influencing cancer cell migration and invasion in a context-dependent manner.
- DAPK1-215 is a significant regulator of malignant progression and a potential prognostic marker in liver cancer.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

